In AD model mice, abnormal expression of EphA4 and EphB2 are detected much earlier than the decrease in synaptic proteins and the onset of cognitive decline (Simón et al., 2009), indicating that Eph receptors may act as early stage markers of AD. Here, EPHA4 is linked to Alzheimer disease.